LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
        • BIOLEAD Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕
    17/04/2020
    17/04/2020

    World Haemophilia Day – Interview with Dr. Ian Winburn (Pfizer)

    On the occasion of World Haemophilia Day we had the pleasure to interview Dr. Ian Winburn, Global Medical Lead within Pfizer’s Rare Disease Business Unit.
    Do you like it?
    Read more
    17/04/2020
    17/04/2020

    World Haemophilia Day – A Message from Paul Perrault (CSL Behring)

    On the occassion of World Haemophilia Day, read a message from Paul Perreault, CEO of CSL Behring.
    Do you like it?
    Read more
    17/04/2020
    17/04/2020

    World Haemophilia Week – Interview with Philip Wood (Sobi)

    During World Haemophilia Week, we caught up with Sobi's Head of Haematology, Philip Wood.
    Do you like it?
    Read more
    10/04/2020
    10/04/2020

    European Industry trade and supply chain needs to respond to Covid-19 – Joint Letter to the EU Trade Ministers

    European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
    Do you like it?
    Read more
    30/03/2020
    30/03/2020

    Biotechnology spearheads the fight against COVID-19

    Learn how biotechnology can contribute towards fighting COVID-19 in our latest blog post.
    Do you like it?
    Read more
    09/03/2020
    09/03/2020

    EuropaBio Position & Policy Recommendations to support EU ATMP Innovation

    To ensure the EU remains a leader in ATMP innovation, this paper outlines and elaborates EuropaBio’s position and policy recommendations to the European Commission across three key focus areas.
    Do you like it?
    Read more
    29/02/2020
    29/02/2020

    Strike Rare Diseases at the Root!

    Read our newest blog on the occasion of Rare Disease Day on the 29th of February.
    Do you like it?
    Read more
    12/02/2020
    12/02/2020

    European Bioeconomy Alliance (EUBA) comments on the European Climate Law Roadmap

    EuropaBio welcomes the foreseen new Circular Economy Action Plan and the plan to publish it with the Industrial Strategy.
    Do you like it?
    Read more
    12/02/2020
    12/02/2020

    Industrial biotechnology solutions for sustainable agriculture

    Read our new report on industrial biotech solutions that support the objectives of the CAP revision programme.
    Do you like it?
    Read more
    04/02/2020
    04/02/2020

    Let’s Beat Cancer with Innovation!

    Biotechnology in the fight against cancer - read our newest blog post.
    Do you like it?
    Read more
    01/02/2020
    01/02/2020

    What if we used biology instead of chemistry for manufacturing?

    Converting plant biomass into high-value chemicals with the help of improved microorganisms.
    Do you like it?
    Read more
    30/01/2020
    30/01/2020

    A Vision for a EU Life Science and Biotechnology Strategy

    In January 2020, EuropaBio finalised a vision document with key recommendations for stimulating a successful life sciences and biotechnology ecosystem in the EU.
    Do you like it?
    Read more
    26/01/2020
    26/01/2020

    What if we could definitively cure AIDS

    A combination of antiviral therapy and genome editing has succeeded in removing the HIV virus from infected mice.
    Do you like it?
    Read more
    25/01/2020
    25/01/2020

    Create immunotherapy treatments for cancer

    Immunotherapy has a long history of use against cancer: in the 1890’s bacteria was injected into a tumour in an attempt to encourage a response by the immune system against the cancer.
    Do you like it?
    Read more
    25/01/2020
    25/01/2020

    Reduce the depletion of small fish in our oceans

    Our ocean’s resources are limited, and the world’s growing population cannot continue to take fish from the seas indefinitely.
    Do you like it?
    Read more
    20/01/2020
    20/01/2020

    EuropaBio comments on the Circular Economy Action Plan

    EuropaBio welcomes the foreseen new Circular Economy Action Plan and the plan to publish it with the Industrial Strategy.
    Do you like it?
    Read more
    20/01/2020
    20/01/2020

    What if we used algae to make biofuel?

    Adjusting a specific algae gene with genome editing, enabling the algae to be a feedstock for biofuels.
    Do you like it?
    Read more
    15/01/2020
    15/01/2020

    Create ‘living drugs’ that treat cancer

    Treatment for certain cancers has taken a huge leap forward thanks to new “living drugs”, created through biotechnology.
    Do you like it?
    Read more
    15/01/2020
    15/01/2020

    What if we could heal sick blood cells

    When “adult” blood causes illnesses, rejuvenating blood cells might be a remedy
    Do you like it?
    Read more
    10/01/2020
    10/01/2020

    What if we could find new tools in the fight against cancer

    There are many types of cancer and many causes that lead to cancer, making the science of finding anti cancer drugs a challenge.
    Do you like it?
    Read more
    Load more
    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.